USE OF ANTI-HER2 ANTIBODY DRUG CONJUGATE IN COMBINATION WITH TYROSINE KINASE INHIBITOR IN… Application WO-2023061472-A1 World Intellectual Property Organisation (WIPO) 20 Apr 2023